Latest Capital Raise News

Imagion Biosystems has secured a AU$3 million capital injection and resumed its collaboration with Siemens, setting the stage to prioritize FDA filings and advance its MagSense® HER2 breast cancer imaging program.

AusQuest Limited has announced a significant porphyry copper-gold discovery at its Cangallo Project in Peru, marking a potential turning point ahead of an active 2025 exploration calendar. The company also secured $2.4 million in funding to advance drilling programs across its Peru and Australian assets.

Triangle Energy reports a solid cash position of $10.89 million as it prepares to drill the Becos-1 exploration well in early 2025, while managing ongoing transitions at the Cliff Head Oil Field and pursuing new ventures in the Philippines and UK.

Asset Vision Co Limited has reported a robust Q2 FY25, marked by significant revenue growth, improved cash flow, and effective cost management, positioning the company well for continued expansion.

Hawk Resources confirms significant near-surface copper mineralisation at its New Years prospect in Utah, alongside the identification of a dozen new exploration targets, setting the stage for an active 2025 drilling campaign.

Magmatic Resources has launched a 3,000m diamond drilling campaign at its Myall Project alongside encouraging soil sampling results at its Wellington North and Parkes projects, signaling advancing exploration momentum.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

Patrys Limited has halted plans for a Phase 1 trial of PAT-DX1 following disappointing GMP production results, pivoting its development efforts towards PAT-DX3 and exploring new partnerships.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.

Top End Energy has taken a major step by acquiring the Kansas Natural Hydrogen Project and advancing its exploration footprint in Australia's Beetaloo Sub-Basin, positioning itself at the forefront of natural hydrogen and unconventional gas development.

LTR Pharma reports compelling clinical results for its nasal spray ED treatment SPONTAN®, demonstrating rapid absorption and strong safety, alongside strategic partnerships and a robust $34 million cash position.

Galileo Mining Ltd’s latest quarterly cash flow report reveals a $706,000 net cash decrease amid ongoing exploration spending, while maintaining a strong cash position of $11.3 million.